These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7853787)

  • 1. Immunoregulation and TGF-beta 1. Suppression of a nephritogenic murine T cell clone.
    Meyers CM; Kelly CJ
    Kidney Int; 1994 Nov; 46(5):1295-301. PubMed ID: 7853787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.
    Meyers CM; Kelly CJ
    J Clin Invest; 1994 Nov; 94(5):2093-104. PubMed ID: 7962556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis.
    Meyers CM; Kelly CJ
    J Clin Invest; 1991 Aug; 88(2):408-16. PubMed ID: 1907613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephritogenic T cells use granzyme C as a cytotoxic mediator.
    Bailey NC; Kelly CJ
    Eur J Immunol; 1997 Sep; 27(9):2302-9. PubMed ID: 9341773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of high affinity transforming growth factor-beta 1 (TGF-beta 1) binding to a nephritogenic T cell results in absence of growth inhibition by TGF-beta 1 and augmented nephritogenicity.
    Bailey NC; Frishberg Y; Kelly CJ
    J Immunol; 1996 Apr; 156(8):3009-16. PubMed ID: 8609423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
    J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta treatment modulates PD-L1 and CD40 expression in proximal renal tubular epithelial cells and enhances CD8 cytotoxic T-cell responses.
    Starke A; Wüthrich RP; Waeckerle-Men Y
    Nephron Exp Nephrol; 2007; 107(1):e22-9. PubMed ID: 17671397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells.
    Banu N; Meyers CM
    Kidney Int; 1999 Sep; 56(3):985-94. PubMed ID: 10469366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Roman JJ; Parham GP; Cannon MJ
    J Virol; 2000 May; 74(10):4729-37. PubMed ID: 10775611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.
    Takahashi M; Nakagawa Y; Berzofsky JA; Takahashi H
    Int Immunol; 2001 Jan; 13(1):43-51. PubMed ID: 11133833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
    Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression.
    Kienzle N; Buttigieg K; Groves P; Kawula T; Kelso A
    J Immunol; 2002 Feb; 168(4):1672-81. PubMed ID: 11823496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
    Caldwell SA; Ryan MH; McDuffie E; Abrams SI
    J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.